Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEARL RCT: Psilocybin-assisted Therapy for Advanced Cancer
NCT07820033Phase 2Not yet recruiting
- Sponsor
- University Health Network
- Start
- Sep 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
A Phase 2 trial of psilocybin in major depressive disorder (MDD), sponsored by University Health Network. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
psilocybin
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT07820033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07820033.